More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Men’s Health Features Glowing Reviews for Medical Marijuana, Inc. Subsidiary HempMeds® Products

Men’s Health Features Glowing Reviews for Medical Marijuana, Inc. Subsidiary HempMeds® Products

by adminAdrianRamirez | Oct 23, 2018 | HempMeds, Press Releases

SAN DIEGO, Oct. 23, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has garnered news coverage in leading international publication Men’s Health....
Medical Marijuana, Inc. CEO to Speak, Subsidiary HempMeds® to Exhibit at Cannabis World Congress in Boston

Medical Marijuana, Inc. CEO to Speak, Subsidiary HempMeds® to Exhibit at Cannabis World Congress in Boston

by adminAdrianRamirez | Oct 16, 2018 | HempMeds, Press Releases

SAN DIEGO, Oct. 16, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at...
Medical Marijuana, Inc. CEO to Speak at CBD Outlook Conference on Humulus-Derived CBD

Medical Marijuana, Inc. CEO to Speak at CBD Outlook Conference on Humulus-Derived CBD

by adminAdrianRamirez | Oct 11, 2018 | HempMeds, Press Releases

SAN DIEGO, Oct. 11, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the company’s Chief Executive Officer Dr. Stuart Titus will speak about Humulus-derived cannabidiol...
Medical Marijuana, Inc. Announces Q3 2018 as the Largest Sales Bookings Quarter in Company History

Medical Marijuana, Inc. Announces Q3 2018 as the Largest Sales Bookings Quarter in Company History

by adminAdrianRamirez | Oct 9, 2018 | HempMeds, Kannaway, Press Releases

SAN DIEGO, Oct. 9, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company and its subsidiary Kannaway® have booked their largest-ever sales revenue quarter in their...
Medical Marijuana, Inc. Subsidiary HempMeds® to Exhibit at Cannabis World Congress and Business Expo in Los Angeles

Medical Marijuana, Inc. Subsidiary HempMeds® to Exhibit at Cannabis World Congress and Business Expo in Los Angeles

by adminAdrianRamirez | Sep 26, 2018 | HempMeds, Press Releases

SAN DIEGO, Sept. 26, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at the...
Medical Marijuana, Inc. Announces Todd Morrow as New President of Subsidiary HempMeds®

Medical Marijuana, Inc. Announces Todd Morrow as New President of Subsidiary HempMeds®

by adminAdrianRamirez | Sep 26, 2018 | HempMeds, Press Releases

SAN DIEGO, Sept. 25, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced Todd Morrow as the new President of the Company’s subsidiary HempMeds®. In his new role, Morrow...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.